Dietary Supplements

Ohio HB 943 Introduced To Prohibit Sale of OTC Diet Pills and Weight-Loss Supplements to Minors

Ohio lawmakers have introduced HB 943 to prohibit retailers from selling over-the-counter diet pills and dietary supplements marketed for weight loss or muscle building to minors in the state. If enacted, the bill would tighten product access controls for youth and signal growing US state-level scrutiny of weight-loss and muscle-building supplements sold through retail channels.

22 May 2026, 18:50legislature.ohio.govUnited States

Delaware House Committee Reports Out HB 394 on Energy Drinks and Caffeinated Supplements for Minors

In May 2026, the Delaware House Health & Human Development Committee voted House Bill 394, which would restrict retail sale of energy drinks and caffeinated dietary supplements to individuals under 18, out of committee and onto the House ready list. If enacted, this measure would impose new age-verification and product-handling obligations and penalties for Delaware retailers and distributors of energy drinks and caffeinated supplements, with enforcement by the Division of Public Health and an effective date one year after enactment.

21 May 2026, 06:40legis.delaware.govUnited States

US FDA Warns FATZorb Weight-Loss Product Contains Hidden Prescription Drug Ingredients

The US FDA has warned that the FATZorb weight-loss product contains undisclosed prescription drug analogues of sibutramine and the laxative phenolphthalein, and has advised consumers not to purchase or use it due to serious cardiovascular and cancer-risk concerns. This underscores persistent safety and compliance risks from adulterated “all natural” weight-loss supplements sold online and in retail, pressuring manufacturers, distributors, and platforms to strengthen supplier controls, surveillance, and response to similar hidden-ingredient products.

20 May 2026, 08:28fda.govUnited States

US FDA: Best Supplements Best Prices Recalls WAP Sensual Enhancement Capsules For Undeclared Sildenafil, Tadalafil And Flibanserin

In May 2026 the US FDA announced a nationwide consumer-level recall of all WAP Sensual Enhancement dietary supplement capsules after testing found undeclared prescription drugs sildenafil, tadalafil and flibanserin in the product. This enforcement action highlights significant safety and liability risks from sexual-enhancement supplements containing hidden APIs, signalling that manufacturers, distributors and online marketplaces must tighten testing, labelling controls and supplier oversight for similar products.

20 May 2026, 07:14fda.govUnited States

Missouri HB3067 Would Establish Kratom Consumer Protection Act for Kratom Sales

Missouri House Bill 3067 would create a Kratom Consumer Protection Act setting statewide labelling, contamination, composition, and age restrictions for kratom product sales, and is currently in the House Emerging Issues Committee. If enacted, kratom manufacturers and retailers would face uniform state pre-emption over local rules, tight limits on 7-hydroxymitragynine and synthetic alkaloids, strict labelling duties, and exposure to fines, misdemeanour liability, and private lawsuits for non-compliance.

19 May 2026, 21:06documents.house.mo.govUnited States

China SAMR Consults on Draft Advertising Review Measures for Drugs, Medical Devices and Health Foods

China’s market regulator has launched a public consultation on sweeping new advertising review measures for drugs, medical devices, health foods and special medical-purpose formula foods, published on 15 May 2026. If adopted, the rules would tighten content and livestream restrictions while simplifying some review procedures, raising compliance stakes for pharma, device and health-food advertising and demanding closer coordination between regulatory and marketing teams.

19 May 2026, 15:27samr.gov.cnChina

New York Senate Bill S10514 Introduces "Synthetic Kratom Kills Act" to Ban Synthetic Kratom and Regulate Natural Products

New York has introduced Senate Bill S10514, the Synthetic Kratom Kills Act, to ban synthetic and adulterated kratom products, cap the potent alkaloid 7-hydroxymitragynine at 2% of total alkaloids, and impose strict testing, labelling, packaging and age-21 controls on natural kratom. If enacted, kratom manufacturers and retailers would face robust third-party testing and disclosure obligations, escalating civil penalties and a defined 90-day plus 180-day implementation window, signalling significantly tighter state scrutiny of kratom and related controlled-substance risks.

18 May 2026, 17:53nysenate.govUnited States

US FDA Warns Against Sâm Xương Khớp Ông Tiên Pain Product Over Hidden Piroxicam and Dexamethasone

In May 2026 the US FDA warned consumers not to use the pain product Sâm Xương Khớp Ông Tiên after testing found undisclosed piroxicam and dexamethasone phosphate in the supplement. This enforcement action highlights ongoing risks from tainted pain and arthritis products and underscores the need for stronger controls on unapproved drug ingredients in consumer supplements and imports.

18 May 2026, 17:25fda.govUnited States

EFSA NDA Issues Opinion on Safety of Beta-Nicotinamide Mononucleotide (β-NMN) as a Novel Food for Adult Food Supplements

In May 2026 EFSA's NDA Panel concluded that chemically synthesised beta-nicotinamide mononucleotide (β-NMN) is safe as a novel food ingredient in adult food supplements at doses up to 300 mg per day, providing a bioavailable source of niacin under the EU novel foods and food supplements frameworks. This scientific opinion sets a clear safety benchmark for forthcoming EU authorisation decisions and gives supplement manufacturers an evidence-based intake limit and specification profile for any β-NMN products targeting the European market.

13 May 2026, 11:58efsa.onlinelibrary.wiley.comEuropean Union

Ukraine: Order No. 203 Tightens Dietary Supplement Composition and Health-Claim Rules (In Force 17 April 2026)

In April 2026 Ukraine’s Ministry of Health brought into force Order No. 203, tightening the compositional, labelling and health-claim rules for dietary supplements and for the addition of vitamins, minerals and certain other substances to foods. Manufacturers and importers of supplements and fortified foods now face clear upper limits for key nutrients, new bans and restrictions on certain ingredients and stricter marketing constraints, requiring prompt reviews of product formulas, labelling and claims for all products placed on the Ukrainian market.

13 May 2026, 09:20zakon.rada.gov.uaUkraine

US FDA Announces Recall of Better Weather Fix Elixir Dietary Supplements for Undeclared Mitragynine and Mitragynine Pseudoindoxyl

In May 2026, the US FDA announced a voluntary recall of Better Weather Fix Elixir dietary supplements after testing found undeclared mitragynine and the more potent mitragynine pseudoindoxyl in approximately 448 boxes of product. This highlights regulatory and liability risks for companies marketing kratom-related or other pharmacologically active ingredients as dietary supplements without transparent labelling and robust ingredient controls.

12 May 2026, 18:21fda.govUnited States

US FDA Warns Against RAPTURE Preworkout With Hidden DMAA Ingredient

In May 2026 the US FDA warned that RAPTURE Preworkout, a dietary supplement sold online and in some stores, contains undeclared DMAA and should not be used. This underscores regulators’ focus on hidden drug ingredients in supplements and signals higher expectations for manufacturers, distributors, and retailers around product testing, labelling, and rapid response to safety findings.

8 May 2026, 06:54fda.govUnited States

US FDA Warns RAPTURE Preworkout Contains Hidden DMAA

US FDA has warned that the RAPTURE Preworkout dietary supplement contains an undeclared stimulant (DMAA) and issued a health fraud notification advising consumers not to purchase or use it. This underscores intensified enforcement focus on dietary supplements and preworkout products that conceal drug-like ingredients, heightening compliance and liability risk for brands using aggressive performance claims.

8 May 2026, 06:54fda.govUnited States

Delaware HB 394 Would Prohibit Sale of Energy Drinks and Caffeinated Dietary Supplements to Minors

In April 2026, Delaware lawmakers proposed HB 394, a bill that would ban retailers from selling energy drinks and caffeinated dietary supplements to individuals under 18 while leaving possession and consumption by minors legal. If enacted, the law would take effect one year after enactment, requiring convenience stores and other beverage and supplement retailers in Delaware to tighten age controls on high-caffeine products sold to minors.

5 May 2026, 07:23legis.delaware.govUnited States

Taiwan TFDA Promotes Voluntary GMP System for Health Supplements

Taiwan’s Food and Drug Administration is promoting a voluntary GMP system for health supplement manufacturers, built on 2020 guidelines and inspection-based certification to align production with international standards. While not legally mandatory, this scheme creates a de facto quality benchmark for Taiwanese supplement suppliers and can support market access and risk assurance for overseas customers relying on documented manufacturing controls.

5 May 2026, 06:46fda.gov.twTaiwanMalaysiaVietnamPhilippinesIndonesia

Brazil Chamber Approves Urgency Regime for Dietary Supplements Control Bill PL 5229/2025

In April 2026 Brazil’s Chamber of Deputies approved an urgency regime for PL 5229/2025, a bill that would overhaul sanitary control of dietary supplements and related enforcement tools. If enacted, this package could move quickly to impose stricter Anvisa registration, testing, labelling, e-commerce and recall obligations on supplement manufacturers and retailers, making early compliance planning and monitoring of the plenary vote critical.

3 May 2026, 14:24camara.leg.brBrazil

EU PAFF General Food Law Committee Publishes May 2026 Agendas on Monacolins and Garcinia Cambogia Supplements

The European Commission’s PAFF General Food Law committee has published May 2026 agendas highlighting a French safeguard ban on Garcinia cambogia food supplements and an EU draft regulation to amend Annex III of Regulation (EC) No 1925/2006 on monacolins from red yeast rice. These meetings signal possible changes to conditions of use for specific food supplement ingredients at both national and EU level, creating reformulation and market-access risks that manufacturers and importers should track closely.

1 May 2026, 17:43food.ec.europa.euEuropean UnionFrance

Brazil Anvisa Orders Recall of Counterfeit Intimate Lubricants and Vitafor Supplements

In April 2026, Brazil’s Anvisa ordered recall, seizure, and prohibition measures against counterfeit K Med intimate lubricants and falsified Vitafor food supplements sold via Shopee after confirming they differed materially from genuine products and were of unknown origin. These actions signal heightened enforcement against falsified consumer health products in Brazil, meaning manufacturers, distributors, and online platforms must tighten supplier verification and product traceability or risk sudden withdrawals, reputational damage, and sanctions.

30 Apr 2026, 06:35gov.brBrazil

China SAMR Consults on Adding Lycopene to Health Food Ingredients Catalogue

China’s market regulator has issued a draft health food ingredients catalogue entry to add lycopene and opened a public consultation running until 10 May 2026. If adopted, this will formalise conditions for using lycopene in Chinese health foods, influencing formulation choices, claim strategies, and filing routes for supplement brands.

29 Apr 2026, 18:04samr.gov.cnChina

Brazil Anvisa Updates Turmeric Supplement Limits and Labelling

Brazil’s health regulator Anvisa has issued a new Normative Instruction tightening permitted dose ranges and mandatory warnings for turmeric (Curcuma longa) food supplements after identifying potential liver risks. Manufacturers and importers now have six months to reformulate affected products, ensure curcuminoid levels sit within new minimum–maximum limits, and implement the specific liver-risk label warning to remain compliant in the Brazilian market.

28 Apr 2026, 16:22anvisalegis.datalegis.netBrazil